Introduction
3-Methylaspartate ammonia-lyase (MAL) catalyzes the reversible amination of mesaconate (1) to give (2S,3S)-3-methylaspartic acid (2) as a major product and (2S,3R)-3-methylaspartic acid (3) as a minor product (Scheme 1). [1, 2] The enzyme is used by the anaerobic bacterium Clostridium tetanomorphum as part of a degradative pathway that converts (S)-glutamic acid via 2 to finally yield acetyl-CoA. [1, 2] MAL is of considerable biocatalytic interest because it also catalyzes the stereo-and regioselective addition of ammonia to several derivatives of 1 to form a number of 3-alkyl-and 3-halo-substituted aspartic acids. [3] Moreover, the broad nucleophile specificity of MAL enables the use of a range of alternative nucleophiles such as methyla-mine, ethylamine, hydrazine, and methoxylamine in the conjugate addition reaction. [4] These properties make MAL a promising biocatalyst for the enantiospecific synthesis of both 3-and N-substituted aspartic acids, which are interesting building blocks for pharmaceutical synthesis.
MAL is a homodimeric enzyme (molecular mass of 45.5 kDa) that requires both monovalent (i.e., K + ) and di-A C H T U N G T R E N N U N G valent (i.e., Mg II ) cations for activity. [1, 2] Several studies have alanine, glutamine, arginine, or histidine. The properties of the mutant proteins were investigated by circular dichroism (CD) spectroscopy, kinetic analysis, and 1 H NMR spectroscopy. The CD spectra of all mutants were comparable to that of wildtype MAL, and this indicates that these mutations did not result in any major conformational changes. Kinetic studies demonstrated that the mutations have a profound effect on the values of k cat and k cat /K M ; this implicates Lys331, His194 and Gln329 as mechanistically important. The 1 H NMR spectra of the amination and deamination reactions catalyzed by the mutant enzymes K331A, H194A, and Q329A showed that these mutants have strongly enhanced diastereoselectivities. In the amination direction, they catalyze the conversion of mesaconate to yield only (2S,3S)-3-methylaspartic acid, with no detectable formation of (2S,3R)-3-methylaspartic acid. The results are discussed in terms of a mechanism in which Lys331, His194, and Gln329 are involved in positioning the substrate and in formation and stabilization of the enolate anion intermediate. been aimed at demonstrating the deamination mechanism of MAL. [5] [6] [7] [8] [9] [10] [11] Some of these have suggested that MAL operates through a carbanion mechanism with rate-limiting CÀN bond cleavage. [5, 6] This proposed mechanism is supported by the A C H T U N G T R E N N U N G observation that C3 hydrogen exchange of the C3-deuterated substrate (2, Scheme 1) with solvent occurs more rapidly than CÀN bond cleavage. Moreover, no primary isotope effect was observed for the deamination of the C3-deuterated substrate. [5, 6] Nonetheless, other reports have questioned this carbanion mechanism, [7] [8] [9] [10] [11] and up until the structure of MAL was reported, the catalytic mechanism of the enzyme remained unresolved.
The crystal structure of MAL from C. tetanomorphum [12] and that of the isozyme from Citrobacter amalonaticus [13] were reported a few years ago. These structures showed that within the functional homodimer, each MAL monomer consists of two domains (Figure 1 A) . The larger C-terminal domain is an eightfold a/b barrel, and the smaller N-terminal domain mainly consists of b strands. The active site carrying the essential Mg II ion is located in a large cleft between the two domains. Structure comparisons identified MAL as a member of the enolase superfamily. [12, 13] Despite little sequence identity, the overall a/ b-barrel topology and the active-site architecture of MAL are strikingly similar to those of enolase, the title enzyme of this superfamily. Interestingly, the members of the enolase superfamily catalyze different reactions but share a common catalytic step: the metal-ion-assisted, general-base-catalyzed abstraction of the a proton of a carboxylic acid substrate to generate an enzyme-stabilized enolate anion intermediate. [14] On the basis of the structural homology to the enolase superfamily, coupled with the earlier results of kinetic isotope studies, it was proposed that MAL functions by using the common enolase catalytic step, and thus generates and stabilizes an enolate anion intermediate (4, Scheme 2). [12, 13] Although a general base catalyst for the deamination activity of MAL has not been determined, Lys331 appears to be a likely candidate because it occupies a similar position to the general base Lys345 in enolase. [12, 13] Moreover, the crystal structure of C. amalonaticus MAL in complex with 2 shows that Lys331 is the only candidate in the vicinity of C3 that can function as a general base catalyst (Figure 1 B) . [13] Two other residues, His194 and Gln329, are implicated in binding the C4 carboxylate group of 2 (Figure 1 B) , [13] and thus are likely candidates for assisting the Mg II ion in stabilizing the enolate anion intermediate. It was further postulated that His194 might also function as the second base (in addition to Lys331) that abstracts the C3 proton of the stereoisomer 3 (Scheme 1). [12] The objective of the present work is twofold. First, we demonstrate the importance of His194, Gln329, and Lys331 for the MAL-catalyzed reactions. Second, we show that mutations of these active-site residues alter the diastereoselectivity of MAL. This led to a single amino acid MAL variant (H194A) that has useful properties for the stereo-selective synthesis of isomerically pure (2S,3S)-3-methylaspartic acid. The results are discussed in terms of a mechanism in Figure 1 . A) Ribbon diagram of the functional homodimeric structure of C. amalonaticus MAL. [13] The location of the active site in each monomer is indicated by the bound Mg II ion, which is shown as a red sphere. The figure was prepared with PyMOL. [27] B) A close-up of the active site of C. amalonaticus MAL in complex with (2S,3S)-3-methylaspartic acid. [13] For clarity, only the Mg II ion (magenta sphere) and the active-site residues His194, Gln329, and Lys331 are shown. The roles of these residues and their interactions are discussed in the text. Observed distances (in ) between active site residues and substrate are indicated. The figure was prepared with PyMOL. [27] Scheme 2. Proposed enolate anion intermediate along the reaction pathway of MAL. which His194, Gln329, and Lys331 are involved in binding and positioning of the substrate, and in formation and stabilization of the enolate anion intermediate.
Results

Expression and purification of MAL
The gene coding for MAL was amplified from genomic DNA of C. tetanomorphum and fused into the start codon of the expression vector pBAD/Myc-His A, resulting in the construct pBADA C H T U N G T R E N N U N G (MAL-His). Sequencing of the cloned MAL gene verified that no mutations had been introduced during the amplification and cloning procedures. The MAL gene in pBADA C H T U N G T R E N N U N G (MAL-His) is under transcriptional control of the araBAD promoter and the recombinant enzyme was produced upon induction with arabinose in E. coli TOP10 as a C-terminal hexahistidine fusion protein. Production of soluble and active MAL was most efficient when cells were cultivated at 17 8C and when 0.004 % (w/ v) arabinose was used. The recombinant enzyme was purified by a one-step Ni-based immobilized metal affinity chromatography protocol, which typically provides 10-15 mg of homogeneous enzyme per liter of culture.
Kinetic and 1 H NMR spectroscopic analysis of the MALcatalyzed amination of 1
A mixture containing MAL, mesaconate (1), and ammonium chloride was monitored by 1 H NMR spectroscopy to verify that the products of the reaction are (2S,3S)-3-methylaspartic acid (2) and (2S,3R)-3-methylaspartic acid (3), as has been previously reported. [2] Indeed, the enzymatic amination of 1 yields 2 and 3, as indicated by signals in the NMR spectra consistent with the structures of these amino acid products (Figure 2 A). [15] Although the 1 H NMR spectra showed signals for both 2 and 3, those corresponding to 2 predominated in the initial spectra whereas signals for 3 appeared only in the later spectra. These observations confirm that MAL catalyzes the rapid conversion of 1 to the natural substrate 2, as well as the slow conversion of 1 to 3. After a 13-day incubation period, the MAL-catalyzed reaction was complete; the reaction resulted in 45 % 2 and 35 % 3.
A previously described assay [3] was used to measure the kinetic parameters for MAL in the amination direction. Accordingly, the rate of amination of 1 was monitored by following the depletion of 1 at 270 nm in 500 mm Tris-HCl buffer (pH 9.0) containing 20 mm MgCl 2 and 400 mm NH 4 Cl at 30 8C. A k cat of 61 AE1 s À1 and a K M of 0.7 AE 0.02 mm were found; this results in a k cat /K M of~8.7 10 4 m À1 s À1 (Table 1 ). Figure 2 . 1 H NMR spectra monitoring the amination of 1 by A) MAL and B) the H194A mutant. The 1 H NMR signals for compounds 1, 2, and 3 are indicated (see the Supporting Information for assignment of the signals). Spectra were recorded after 1 h, 7 d, and 13 d, as shown from left to right, respectively. The 1 H NMR spectra of the K331A and Q329A mutants (not shown) were comparable to those of the H194A mutant; that is, there was no detectable formation of 3 in the incubation mixtures. The less prominent singlets at d1.20 and 2.11 ppm correspond to impurities resulting from multiple additions of protein. Kinetic and 1 H NMR spectroscopic analysis of the MALcatalyzed deamination of 2
The rate of deamination of 2 by MAL was monitored by following the formation of 1 at 240 nm in 500 mm Tris-HCl buffer (pH 9.0) containing 20 mm MgCl 2 and 1 mm KCl at 30 8C. [3] For the deamination of 2, a k cat of 89 AE 4 s À1 and a K M of 1.0 AE 0.1 mm were found; this results in a k cat /K M of 8.9 10 4 m À1 s À1 ( Table 2) .
A mixture containing MAL and 2 was also monitored by 1 H NMR spectroscopy to verify that the product of the reaction is 1. The enzymatic conversion of 2 yields 1, as indicated by a singlet at 1.74 ppm and a singlet at 6.28 ppm ( Figure S4 in the Supporting Information), which correspond to the protons at the C3 methyl group and C2, respectively. In addition, signals corresponding to 3 are also present. After a 13-day incubation period, the MAL-catalyzed reaction results in 41 % 1 and 2 % 3. [16] Hence, 1 is the major product of the MAL-catalyzed conversion of 2.
H NMR spectroscopic analysis of the MAL-catalyzed
H NMR spectroscopic analysis of the diastereoisomer 3 revealed that the provided material contained 94-95 % of the required diastereoisomer 3 and 5-6 % of the unwanted diastereoisomer 2. This finding precluded the use of the material in kinetic experiments. Nevertheless, it was possible to monitor the deamination of 3 by 1 H NMR spectroscopy and identify the products of the reaction. The 1 H NMR spectra showed the disappearance of signals corresponding to 3 and the appearance of new signals corresponding to 1 and 2. Signals corresponding to 1 predominated in the initial spectra whereas signals for 2 increased in the later spectra. After a lengthy incubation period (approximately two weeks), the MAL-catalyzed reaction was complete; it yielded 1 in 79 % and 2 in 12 % ( Figure S5 ).
Mutagenesis of His194, Lys331, and Gln329
To investigate the importance of His194, Lys331, and Gln329 for the activity and stereoselectivity of MAL, single site-directed mutants were constructed in which His194 and Gln329 were replaced with either an alanine or arginine (H194A, H194R, Q329A, and Q329R) and Lys331 with a glycine, alanine, glutamine, histidine, or arginine (K331G, K331A, K331Q, K331H, and K331R). DNA sequencing verified that only the intended mutations had been introduced into each mutant gene. The mutants were overexpressed in E. coli strain TOP10 and purified to > 95 % homogeneity (as assessed by SDS-PAGE) by using the Ni-based immobilized metal affinity chromatography protocol described for wild-type MAL. The yields (in milligrams of A C H T U N G T R E N N U N G homogeneous protein per liter of cell culture) of the mutants varied from 10 to 20 mg.
It was shown by nondenaturing PAGE (data not shown) that the native molecular mass for each mutant is comparable to that of wild type; this demonstrates that the oligomeric association of the mutants was still intact. The structural integrity of the mutants was also assessed by circular dichroism (CD). The CD spectra of the mutants were comparable to that of the wild type; this indicates that these mutations did not result in any major conformational changes ( Figure S6 ).
Kinetic and 1 H NMR spectroscopic analysis of the A C H T U N G T R E N N U N G deamination of 2 by the MAL mutants
The activities of the MAL mutants were initially assayed by using the natural substrate 2. It was found that substitution of Lys331 by a glycine, alanine, histidine, glutamine, or arginine essentially abolished enzymatic activity, and this underscores the importance of this residue for the MAL-catalyzed deamination of 2. Under the conditions of the kinetic assays, no activity could be detected for these mutants. Substitution of either His194 or Gln329 by an arginine also resulted in mutant A C H T U N G T R E N N U N G enzymes that were inactive. The H194A and Q329A mutants, however, deaminate 2 at a reduced catalytic efficiency ( Table 2 ). For the H194A mutant, there is a slight (1.8-fold) increase in K M and a~160-fold decrease in k cat ; this results in ã 290-fold reduction in k cat /K M . For the Q329A mutant, there is a~8900-fold decrease in k cat , whereas the K M is not affected. Hence, this results in a~8900-fold reduction in k cat /K M .
The deamination activities of the three alanine mutants (H194A, K331A, and Q329A) were also assessed by 1 H NMR spectroscopy after a lengthy (approximately two weeks) incubation period. With 2, the H194A and Q329A-catalyzed reactions resulted in a 40 % yield of 1 and a 3 % yield of 3, whereas the K331A-catalyzed reaction showed only a trace amount of product (2 % 1 and 2 % 3). [16] These observations parallel those of the kinetic assays and suggest that Lys331 is more critical for the deamination activity of MAL than His194 and Gln329.
pH dependence of the kinetic parameters of MAL and the H194A mutant by using 2
To determine the pK a of the basic group on the enzyme important for catalysis (the presumed general base catalyst) and to evaluate the effect of the alanine mutation on this pK a , the pH dependence of the k cat /K M for the MAL and H194A-catalyzed deamination of 2 was determined over the pH range 6.0-9.5. The other two alanine mutants, K331A and Q329A, were not active enough with 2 and thus could not be measured. The Table 2 . Kinetic parameters for the MAL, K331A, H194A, and Q329A-catalyzed deamination of (2S,3S)-3-methylaspartic acid (2) log A C H T U N G T R E N N U N G (k cat /K M ) versus pH profiles of MAL and H194A both show a single ascending limb with a slope of one ( Figure 3 ). [17] For wild-type MAL, a pK a value of 7.8 AE 0.1 was found. For the H194A mutant, a pK a value of 8.2 AE 0.1 was found. Hence, within the estimated errors, there is no significant effect of the H194A substitution on the pK a for the ascending limb. 1 H NMR spectroscopic analysis of the K331A, H194A, and Q329A-catalyzed deamination of 3
The deamination of the nonnatural substrate 3 by the alanine mutants was monitored by 1 H NMR spectroscopy. After a 13 day-incubation period, the Q329A-catalyzed reaction resulted in a 10 % yield of 1. The contaminant 2, which is the natural substrate for the enzyme, was selectively processed by Q329A at a much faster rate than for 3. The H194A mutant also processed the contaminant 2 (this resulted in a 6 % yield of 1), but showed no detectable activity towards 3. The mixture containing the K331A mutant showed no product.
Kinetic and 1 H NMR spectroscopic analysis of the amination of 1 by the MAL mutants
The kinetic parameters for the amination reactions catalyzed by the MAL mutants were determined and compared to those measured for the wild-type MAL-catalyzed amination of 1 (Table 1) . For the Q329A mutant, there is a slight increase in K M (~2.4-fold) and a~240-fold decrease in k cat , which results in ã 600-fold reduction in k cat /K M . For the H194A mutant, there is a 20-fold increase in K M and only about a sevenfold decrease in k cat , which results in a~140-fold reduction in k cat /K M . Under the conditions of the kinetic assay, no activity could be detected for the other mutants (H194R, Q329R, K331G, K331A, K331Q, K331H, and K331R).
The amination of 1 by the three alanine mutants (H194A, Q329A, and K331A) was also monitored by 1 H NMR spectroscopy to identify the diastereoisomeric products of the reaction. 
Discussion
Previous studies of the stereoselectivity of C. tetanomorphum MAL indicated that the wild-type enzyme catalyzes the reversible anti and syn-addition of ammonia to mesaconate (1) to yield (2S,3S)-3-methylaspartic acid (2) and (2S,3R)-3-methylaspartic acid (3), respectively. [2, 9] The determination of the X-ray structure of C. amalonaticus MAL in complex with the natural substrate 2 has provided the essential structural information for the identification of the substrate interactions within the enzyme-substrate complex. [13] Guided by the structure of this complex, we have selected three active site residues in C. tetanomorphum MAL [12] for mutagenesis to provide insight into the structural determinants of the reactivity and stereoselectivity of MAL. [18] The results of these studies are interpreted here and discussed in terms of a two-base mechanism, in which the proton abstraction/addition steps are effected by S and R-specific general base/acid catalysts juxtaposed on either side of the (chiral) C3 carbon of the substrate.
We first verified that both 2 and 3 are formed as products of the MAL-catalyzed amination of 1 by 1 H NMR spectroscopy. It was found that stereoisomer 2 is formed at a rate much faster than stereoisomer 3 (at equilibrium, the ratio of 2/3 is approximately 1.3). Second, we confirmed that MAL does not catalyze the direct epimerization of the two stereoisomers. This was evident from a prolonged incubation of MAL with 2; this yielded 1 as the major product and gave only a trace amount of 3. Another notable observation is that the incubation of MAL with 3 finally gives 2 (in 12 % yield), but only after a significant amount of 1 accumulates in the reaction mixture. This suggests that MAL first catalyzes the syn-elimination of ammonia from 3 to yield 1, and this is followed by the anti-addition of ammonia to 1 to give 2. These observations indicate that the formation of 2 and 3 as products of the MAL-catalyzed amination of 1 is not the result of the MAL-catalyzed amination of 1 to 2 followed by the slow direct epimerization of 2 to 3. Hence, MAL indeed catalyzes the rapid anti-addition and the much slower syn-addition of ammonia to 1 to give 2 and 3,
The crystal structure of C. amalonaticus MAL in complex with 2 shows that Lys331 is the only candidate in the vicinity of C3 that can function as the Sspecific base/acid catalyst (Figure 1 B) . [13] This lysine residue is conserved in all characterized 3methylaspartate ammonia-lyases. Moreover, a comparison of the active-site structures of MAL and enolase shows that Lys331 in MAL superimposes to within 1 of the previously identified general base Lys345 in enolase. [13] To assess its role in catalysis, we have mutated Lys331 to a glycine, alanine, histidine, glutamine, or arginine. Examination of the kinetic properties for these mutants clearly shows that Lys331 is an essential residue in the MAL-catalyzed reactions because all five mutations at this position result in a dramatic loss of activity. (There is a > 10 7 -fold drop in the value of k cat / K M with 2). The mutant enzymes appear to retain an intact overall structural integrity as shown by CD spectroscopy. It is therefore reasonable to conclude that Lys331 is crucial for catalysis because it functions as the S-specific base catalyst in the deamination of 2 and, hence, as the acid catalyst (the conjugate acid of Lys331) in the corresponding reverse anti-addition reaction (Scheme 3).
From the ascending limb of the log (k cat /K M ) versus pH profile of MAL, a residue with a pK a of approximately 7.8 that must be deprotonated for optimal activity, might be the general base catalyst involved in abstraction of the C3 proton of 2. Whereas the pK a value of Lys331 in MAL has not been directly measured by NMR spectroscopy, it can be inferred from these results that the kinetic pK a value of 7.8 is likely due to Lys331.
In the structure of the MAL-substrate complex, His194 and Gln329 are hydrogen bonded to the C4 carboxylate group of 2 (Figure 1 B) . [13] This suggests roles for these residues in binding the substrate, and possible intermediates, in the reaction mechanism of MAL. In this study, His194 and Gln329 were mutated to assess their role in catalysis. The best-characterized mutants are the H194A and Q329A mutants, which have measurable activity and show no significant differences in their CD spectra compared to that of wild-type MAL. Examination of the kinetic properties for the two mutants in the deamination direction (by using 2) shows that there is a small effect on K M and a much larger effect on k cat . This suggests important roles for His194 and Gln329 in catalysis. The somewhat larger effect of these mutations on the value of K M in the amination direction might suggest a more important role for His194 and Gln329 in binding 1 than 2.
A major part of the loss in activity of the H194A and Q329A mutants is likely due to the removal of optimal hydrogenbonding interactions with the proposed enolate anion intermediate formed at the C4 carbonyl position of 2 (or 1 in the corresponding reverse reaction); this makes the abstraction of a proton from the C3 position less favorable. Presumably, His194 and Gln329, together with the essential Mg II ion, polarize the C4 carboxylate group and stabilize the enolate anion [13] (shown in gray) and the other with the most-favored conformation of the modeled nonnatural substrate (2S,3R)-3-methylaspartic acid (3) (shown in cyan). The orientation of 2 suggests that its C3 proton is abstracted by Lys331, whereas the orientation of 3 suggests that its C3 proton is abstracted by His194. The figure was prepared with Discovery Studio 1.7. intermediate 4 that is formed upon abstraction of the C3 proton (Scheme 3). An electrophilic residue, the role of which is to assist the Mg II ion in providing the charge neutralization that is essential for the activation of the a proton and for stabilizing the enolate anion intermediate, has also been identified in mandelate racemase (Lys164) and some other enolase superfamily members. [14, 19] In addition to its presumed role as electrophilic residue, His194 might also function as the R-specific base/acid catalyst. Naismith and co-workers first proposed this role for His194 based on structure comparisons of enolase superfamily members. [12] The sidechain of His194 superimposes on that of the second base Lys166 in mandelate racemase and the principal base Lys213 in glucarate dehydratase. [12] Moreover, if the threedimensional structure of 3 is modeled into the active site of MAL by using the X-ray structure of MAL in complex with 2 as a guide, then the C3 proton of 3 is faced towards the imidazole nitrogen atom (Ne2) of His194 (Figure 4) . Our experiments clearly show that His194 is an important determinant of the stereoselectivity of MAL because an alanine mutation at this position results in a mutant enzyme that appears to have lost its ability to catalyze proton abstraction/addition from the R face (the His194 side) of the substrate. Indeed, the H194A mutant has no detectable deamination activity with 3 and catalyzes the highly stereoselective conversion of 1 to 2, with no detectable formation of 3. Taken together, these observations are consistent with a role of His194 as the R-specific general base catalyst for the deamination of 3 and, hence, as the acid catalyst (the conjugate acid of His194) in the corresponding A C H T U N G T R E N N U N G reverse syn-addition reaction.
In view of the presumed role of His194 as the R-specific general base/acid catalyst, mutation of Lys331 or Gln329 to an alanine gave results that were somewhat unexpected. Initially, it was thought that mutation of Lys331 would only effect proton abstraction/addition from the S face (the Lys331 side) of the substrate. Surprisingly, however, the K331A mutant lost its ability to catalyze proton abstraction/addition from the R face of the substrate, but it retained a very low-level proton abstraction/addition activity from the S face of the substrate. Like K331A, the Q329A mutant also catalyzes the highly stereoselective conversion of 1 to 2 with no detectable formation of 3. But, in contrast to K331A, the Q329A mutant still has a detectable low-level deamination activity with 3.
One potential explanation for the alteration in diastereoselectivity of the K331A and Q329A mutants is that mutation of Lys331 or Gln329 to an alanine causes different interactions between substrate and enzyme and might influence the geometry of a Michaelis complex that undergoes proton abstraction/ addition from the R face of the substrate. In this scenario, the removal of the native interactions with the substrate places the substrate in an unfavorable position to undergo proton A C H T U N G T R E N N U N G abstraction/addition by His194, the presumed R-specific base/ acid catalyst. Another explanation for the loss in proton abstraction/addition activity from the R face of the substrate is that mutation of Lys331 or Gln329 by an alanine directly influences the orientation of the His194 sidechain. Crystallographic studies of the H194A, K331A, and Q329A mutants, and of wild-type MAL in complex with 3, would be an important step toward understanding how these mutations affect the stereochemical properties of MAL.
The current investigation has clearly demonstrated that the stereoselectivity of MAL can be enhanced by mutation of the active-site residues His194, Lys331, and Gln329. Interestingly, the mutation of Gln73 or Gln172, two residues implicated in binding the C2 amino group of 2 (Figure 4) , to an alanine has a profound effect on the values of k cat and k cat /K M (with 1 and 2) but no significant effect on the stereoselectivity of MAL. Like wild-type MAL, the Q73A and Q172A mutants catalyze the amination of 1 to give both 2 and 3 as products (H.R., G.J.P., unpublished results, 2009). Hence, His194, Gln329, and Lys331 appear to be the major determinants of the stereoselectivity of MAL. The enhancement of the stereoselectivity should make it possible to utilize single amino acid variants of MAL (e.g., H194A) in stereo-and regioselective amination reactions to produce 3-substituted aspartic acid isomers with a very high diastereomeric excess. Such efforts are being pursued in our laboratories.
Experimental Section
Materials: dl-threo-3-methylaspartic acid, mesaconic acid, and larabinose were purchased from Sigma-Aldrich. (2S,3R)-3-Methylaspartic acid (95 % purity) was purchased from Syncom (Groningen, The Netherlands). Ingredients for buffers and media were obtained from Duchefa Biochemie (Haarlem, The Netherlands) or Merck. Molecular biology reagents, including restriction enzymes, PCR reagents, T4 DNA ligase, DNA ladders, agarose, and protein molecular weight standards were obtained from F. Hoffmann-LaRoche, Promega, Invitrogen, Finnzymes (Espoo, Finland) or New England Biolabs. PCR purification, gel extraction, and Miniprep kits were provided by Macherey-Nagel (Düren, Germany). Pre-packed PD-10 Sephadex G-25 columns were purchased from GE Healthcare Bio-Sciences. Oligonucleotides for DNA amplification were synthesized by Operon Biotechnologies (Cologne, Germany).
Bacterial strains, plasmids, and growth conditions: E. coli strain XL1-Blue (Stratagene, La Jolla, CA) was used for cloning and isolation of plasmids. E. coli strain TOP10 (Invitrogen) was used in combination with the pBAD/Myc-His A vector (Invitrogen) for recombinant protein production. C. tetanomorphum ATCC 15 920, the genomic DNA source for the MAL gene, was purchased from DSMZ GmbH (Braunschweig, Germany). E. coli cells were grown in Luria-Bertani (LB) media. When required, Difco agar (15 g/ L), ampicillin (Ap, 100 mg mL À1 ), and/or arabinose (0.004 % w/v) were added to the medium.
General methods: Techniques for restriction enzyme digestions, ligation, transformation, and other standard molecular biology manipulations were based on methods described elsewhere [20] or as suggested by the manufacturer. The PCR was carried out in a DNA thermal cycler (model GS-1) obtained from Biolegio (Nijmegen, The Netherlands). DNA sequencing was performed by ServiceXS (Leiden, The Netherlands) or Macrogen (Seoul, Korea). Protein was analyzed by PAGE under either denaturing conditions by using SDS or native conditions on gels containing polyacrylamide (7.5-10 %). The gels were stained with Coomassie brilliant blue. Protein concentrations were determined by the Waddell method. [21] Kinetic data were obtained on a V-650 spectrophotometer from Jasco (IJsselstein, The Netherlands). The solutions in the cuvettes were 2242 www.chembiochem.org mixed by using a stir/add cuvette mixer (Bel-Art Products, Pequannock, NJ, USA). The kinetic data were fitted by nonlinear regression data analysis by using the Grafit program (Erithacus, Software Ltd., Horley, UK) obtained from Sigma Chemical Co. The CD spectra were recorded on a model 62A-DS spectropolarimeter from AVIV Biomedical Inc. (Lakewood, NJ, USA). 1 H NMR spectra were recorded on a Varian Inova 500 (500 MHz) spectrometer by using a pulse sequence for selective presaturation of the water signal. Chemical shifts for protons are reported in parts per million scale (d scale) downfield from tetramethylsilane and are referenced to protium (H 2 O: d = 4.67).
Construction of the expression vector for the production of MAL: The MAL gene was amplified by PCR by using two synthetic primers, a small amount of biomass from C. tetanomorphum as the genomic DNA source, and the PCR reagents supplied in the Expand High Fidelity PCR system by following the protocol supplied with the system (F. Hoffmann-La Roche, Ltd.). The forward primer (5'-ATA CAT ATG AAA ATT GTT GAC GTA CTT TG-3') contains a NdeI restriction site (in bold) followed by 20 bases corresponding to the coding sequence of the MAL gene. The reverse primer (5'-CAT AAG CTT TTT TCT TCT TCC TAC AAG-3') contains a HindIII restriction site (in bold) followed by 18 bases corresponding to the complementary sequence of the MAL gene. The resulting PCR product and the pBADN/Myc-His A vector were digested with NdeI and HindIII restriction enzymes, purified, and ligated by using T4 DNA ligase. The pBADN/Myc-His A vector is a variant of the commercially available pBAD/Myc-His A vector in which the unique NcoI site is replaced with NdeI. [22] Aliquots of the ligation mixture were transformed into competent E. coli TOP10 cells. Transformants were selected at 37 8C on LB/Ap plates. Plasmid DNA was isolated from several colonies and analyzed by restriction analysis for the presence of the insert. The cloned MAL gene was sequenced to verify that no mutations had been introduced during the amplification of the gene. The newly constructed expression vector was named pBADA C H T U N G T R E N N U N G (MAL-His).
Construction of MAL mutants:
Mutants of MAL were generated by the overlap extension PCR method [23] by using plasmid pBAD-A C H T U N G T R E N N U N G (MAL-His) as the template. The final PCR products were gel purified, digested with the NdeI and HindIII restriction enzymes, and A C H T U N G T R E N N U N G ligated in-frame with both the initiation ATG start codon and the sequence that codes for the polyhistidine region of the expression vector pBADN/Myc-His A. All mutant genes were completely sequenced (with overlapping reads) to verify that only the intended mutation had been introduced.
Expression and purification of MAL wild type and mutants: The MAL enzyme, either wild type or mutant, was produced in E. coli TOP10 by using the pBAD expression system. Fresh TOP10 cells containing the appropriate expression plasmid were collected from a LB/Ap plate by using a sterile loop and used to inoculate LB/Ap medium (15 mL). After growth for 8 h at 37 8C, a sufficient quantity of the culture was used to inoculate fresh LB/Ap medium (300 mL) containing arabinose (0.004 %, w/v) in a 1 L Erlenmeyer flask to an initial A 600 of~0.1. Cultures were grown for 4 d at 17 8C with A C H T U N G T R E N N U N G vigorous shaking. Cells were harvested by centrifugation (6000 g, 15 min) and stored at À20 8C until further use.
In a typical purification experiment, cells (of three 300 mL cultures) were thawed, combined, and suspended in lysis buffer (10 mL, 50 mm NaH 2 PO 4 , 300 mm NaCl, 10 mm imidazole, pH 8.0). Cells were disrupted by sonication for 4 1 min (with 4-6 min rest in between each cycle) at a 60 W output, after which unbroken cells and debris were removed by centrifugation (10 000 g, 45 min). The supernatant was filtered through a 0.45 mm pore diameter filter and incubated with Ni-NTA (1 mL slurry in a small column at 4 8C for ! 18 h), which had previously been equilibrated with lysis buffer. The nonbound proteins were eluted from the column by gravity flow. The column was first washed with lysis buffer (10 mL) and then with buffer A (50 mm NaH 2 PO 4 , 300 mm NaCl, 20 mm imidazole, pH 8.0; 10 mL). Retained proteins were eluted with buffer B (50 mm NaH 2 PO 4 , 300 mm NaCl, 250 mm imidazole, pH 8.0; 2.0 mL). Fractions (~0.5 mL) were analyzed by SDS-PAGE on gels containing acrylamide (10 %), and those that contained purified MAL were combined and the buffer was exchanged against Tris buffer (50 mm, pH 8.0), containing MgCl 2 (2 mm) and KCl (0.1 mm), by using a prepacked PD-10 Sephadex G-25 gel filtration column. The purified enzyme was stored at + 4 8C or À80 8C until further use.
Circular dichroism spectroscopy: Circular dichroism spectra of the wild-type protein and the purified mutants were measured in Tris-HCl buffer (10 mm, pH 8.0), containing MgCl 2 (2 mm) and KCl (0.1 mm), at a concentration of approximately 3.2 mm in a CD cell with a 1.0 mm optical path length.
Kinetic assays: The assays used for the spectrophotometric determination of the deamination of 2 and to follow the amination of 1 are based on protocols reported elsewhere. [3] Accordingly, the deamination of 2 by MAL was monitored by following the formation of 1 at 240 nm (e = 3850 m À1 cm À1 ) in Tris-HCl buffer (500 mm, pH 9.0) containing MgCl 2 (20 mm) and KCl (1 mm) at 308C. An aliquot of MAL, either wild type or mutant, was diluted into buffer (20 mL) and incubated for 30 min at 30 8C. The 30 min equilibration period resulted in more reproducible kinetic data. Subsequently, a portion (1 mL) was transferred to a 10 mm quartz cuvette and the enzyme activity was assayed by the addition of a small quantity (1-10 mL) of 2 from a stock solution. The stock solutions were made up by dissolving the appropriate amount of dl-threo-3methylaspartic acid (a 1:1 mixture of the enantiomers (2S,3S)-3methylaspartic acid and (2R,3R)-3-methylaspartic acid) in Tris-HCl buffer (500 mm, pH 9.0) to obtain the desired concentration of 2. The (2R,3R)-enantiomer is neither a substrate nor an inhibitor of MAL. The concentrations of 2 that were used in the assay ranged from 0.5 to 20 mm.
The rate of amination of 1 was monitored by following the depletion of 1 at 270 nm (e = 482 m À1 cm À1 ) in Tris-HCl buffer (500 mm, pH 9.0) containing MgCl 2 (20 mm) and NH 4 Cl (400 mm) at 308C. [3] An aliquot of MAL, either wild-type or mutant, was diluted into buffer (20 mL) and incubated for 30 min at 30 8C. Subsequently, a portion (1 mL) was transferred to a 1 or 10 mm quartz cuvette and the enzyme activity was assayed by the addition of a small quantity (1-10 mL) of 1 from a stock solution. The stock solutions were made up in Tris-HCl buffer (500 mm, pH 9.0). The concentrations of 1 that were used in the assay ranged from 0.1 to 50 mm. pH dependence of the kinetic parameters of MAL and H194A: The pH dependence of the steady-state kinetic parameters was determined in Tris buffer (500 mm) containing MgCl 2 (20 mm) and KCl (1 mm) with pH values ranging from 6.0-9.5. For each pH value, a sufficient quantity of enzyme (from a stock solution in Tris buffer (50 mm, pH 8.0) containing 2 mm MgCl 2 and 0.1 mm KCl) was equilibrated in buffer (20 mL) for 30 min at 30 8C. The addition of enzyme did not significantly change the pH. Subsequently, aliquots (1 mL) were removed and assayed for activity by using concentrations of 2 ranging from 0.5-50 mm. Stock solutions of 2 were made in Tris buffer (500 mm). The pH of the stock solutions was adjusted to each desired pH value (6.0-9.5). The volume of substrate added was 20 mL or less in all experiments. 1 H NMR spectroscopic product analysis of the amination of 1 by MAL wild type and mutants: The products of the amination of 1 by wild-type MAL and the MAL mutants were identified by 1 H NMR spectroscopy by using a procedure described elsewhere [2] with the following modifications. In separate experiments, MAL, K331A, H194A, or Q329A was incubated with 1, and the reactions were A C H T U N G T R E N N U N G followed by 1 H NMR spectroscopy. Reaction mixtures consisted of Na 2 HPO 4 buffer (350 mL; 100 mm, containing 20 mm MgCl 2 and 1 mm KCl, pH 9.0), D 2 O (50 mL), NH 4 Cl (100 mL, 5 m), and an aliquot of 1 (100 mL) from a 500 mm stock solution. The stock solution of 1 was made in Na 2 HPO 4 buffer (100 mm), and the pH of the solution was adjusted to 9.0 with aliquots of an aq 1 m NaOH solution. A quantity of enzyme (50 mL) was added from a stock solution and the reaction mixtures were incubated at 22 8C. The concentrations of the protein stock solutions were MAL (12.3 mg mL À1 ), K331A (13.4 mg mL À1 ), H194A (10.7 mg mL À1 ), and Q329A (14.4 mg mL À1 ). Additional aliquots of enzyme (50 mL) were added to the individual mixtures after 3, 6, 9, and 12 days. 1 H NMR spectra were recorded 1 h, 3 d, 7 d, and 13 d after the first addition of enzyme. Product amounts were estimated by integration of the signals corresponding to 2 and 3, if present. The 1 H NMR signals for 1, 2, and 3 are given in the Supporting Information (Figures S1, S2 and S3). 1 H NMR spectroscopic product analysis of the reaction of wildtype and mutant MAL with 2 or 3: The products of the deamination of 2 or 3 by wild-type MAL and the MAL mutants were identified by 1 H NMR spectroscopy. In separate experiments, MAL, K331A, H194A or Q329A was incubated with 2 or 3. Reaction mixtures consisted of Na 2 HPO 4 buffer (400 mL; 100 mm, containing 20 mm MgCl 2 and 1 mm KCl, pH 9.0), D 2 O (40 mL), and an aliquot of 2 or 3 (150 mL) from a 500 mm stock solution. The stock solutions of 2 and 3 were made in Na 2 HPO 4 buffer (100 mm), and the pH of the solutions was adjusted to 9.0 with aliquots of a 1 m aq NaOH solution. A quantity of enzyme (50 mL) was added from a stock A C H T U N G T R E N N U N G solution and the reaction mixtures were incubated at 22 8C. The concentrations of the protein stock solutions were MAL (15.7 mg mL À1 ), K331A (12.8 mg mL À1 ), H194A (7.4 mg mL À1 ), and Q329A (8.8 mg mL À1 ). Additional aliquots of enzyme (50 mL) were added to the individual mixtures after 3, 6, 9, and 12 d. The eight reaction mixtures were examined by 1 H NMR spectroscopy after a 13-day incubation period, and the product amounts were estimated by integration of the signals corresponding to 1, 2 and 3, if present.
Molecular docking: Comparative docking simulations were performed by using Discovery Studio 1.7 (Accelrys, San Diego, CA, USA). Models for the enzymes were based on the structures of C. amalonaticus MAL in complex with 2 [13] and C. tetanomorphum MAL in the absence of a bound ligand [12] (PDB IDs: 1KKR and 1KCZ, respectively). Hydrogen atoms were added automatically. Models of the substrates were constructed, and the energy was minimized by using the CHARMm force field. [24] Minimization was done by using a dielectric constant of one and a nonbonded cutoff distance of 12 . The substrates were docked by using the grid-based approach CDOCKER, a molecular dynamics (MD) simulated-annealingbased algorithm, [25, 26] by using the experimentally determined binding site for 2 in C. amalonaticus MAL as coordinates. Initially, the enzyme active site was fixed, and the atoms of the substrate, either 2 or 3, were allowed to move. For subsequent rounds of minimization, the constraints on the amino acids forming the active site were removed and replaced by distance constraints based on the reported distances observed in X-ray structure of MAL complexed with 2. A final minimization step was applied to each ligand-docked pose that consisted of 300 steps of steepest descent followed by 2500 iterations of the adopted basis-set Newton-Raphson algorithm with an energy tolerance of 0.001 Kcal mol À1 .
Abbreviations: Ap, ampicillin; CD, circular dichroism; LB, Luria-Bertani; MAL, 3-methylaspartate ammonia-lyase.
